BERREY M MICHELLE

PrivateCIK: 1397329
Location

PRINCETON, NJ

BERREY M MICHELLE (President, R&D and CMO) reported 2 transactions at INTERCEPT PHARMACEUTICALS, INC.

Review the transaction codes below to understand the nature of each event.

InsiderBERREY M MICHELLECIK 1397329
Officer· President, R&D and CMO
Since Jun 2021
-214.74K
Net shares
Net seller
$1.52M
Total sold
0
Open market trades
0B · 0S
5
Total transactions
214.74K disposed
Non-Derivative Transactions2

Common Stock

Direct
U · U

Shares

28.35K

Price / share

$19.00

Trade value

$538.63K

% of position

New position
11/8/2023
28.35K0.00

Common Stock

Direct
D · Disposition

Shares

51.79K

Price / share

$19.00

Trade value

$984.01K

% of position

New position
11/8/2023
51.79K0.00
Total

Net shares

80.14K

Net value

-$1.52M

Derivative Transactions3

Option to Purchase Common Stock

Direct
D · Disposition
Converts to

Common Stock

17.60K shares

Shares

17.60K

Strike price

14.44

Held after

0.00

Exercisable

11/8/2023

Option to Purchase Common Stock

Direct
D · Disposition
Converts to

Common Stock

24K shares

Shares

24K

Strike price

18.40

Held after

0.00

Exercisable

11/8/2023

Option to Purchase Common Stock

Direct
D · Disposition
Converts to

Common Stock

93K shares

Shares

93K

Strike price

21.38

Held after

0.00

Exercisable

11/8/2023
BERREY M MICHELLE — Insider Transaction (Form 4) Filed Nov 13, 2023 | Finecho